Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
1,590
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
72
Comments
0
Likes
2

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Presented By,Group No-01Animesh Amal (01)Madhura Jagtap (10)Bosco James (15)Shafaatali (18)Bhavika Sachdev (23)
  • 2. Contents• Mission & Vision• Novartis India• History• People• Top 10 Brands• Current Alliance• Product Mix• Presence• Financial Data• Stock Price• R & D• References
  • 3. Mission & Vision• We want to discover, develop and successfullymarket innovative products to prevent andcure diseases, to ease suffering and toenhance the quality of life.• We also want to provide a shareholder returnthat reflects outstanding performance and toadequately reward those who invest ideas andwork in our company.
  • 4. Novartis IndiaMissionInnovative products, Outstanding performance,Ideas and work.VisionA better today and tomorrow for patients.DirectorsChristopher Snook (Chairman)Ranjit Shahani (Vice Chairman & M.D.)
  • 5. History1996 – The shareholders of Sandoz and Ciba-Geigy approve of the merger.1997- Novartis announces to acquire cropprotection business of Merck & co.2000 - Novartis seeds are merged withAstrazeneca’s agribusiness operations to formSyngenta.2001- FDI grants approval of Glivec.2003- Novartis unites it’s generics business underone single global brand - Sandoz.
  • 6. History of Novartis195819701996Present
  • 7. PeopleFull-time associates 2012 total: 127 724Associates by region, 2012
  • 8. Top 10 Brands of Novartis India
  • 9. Current Alliance of Novartis
  • 10. Product MixProduct Mix WidthPharmaceuticalsAlcon (Eye Care)Sandoz(Generics)Over The CounterVaccines and DiagnosticsAnimal Health
  • 11. PharmaceuticalsAutoinflammatory and AutoimmuneDiseaseIlarisHypertension Amturnide, Diovan, Exforge, LotrelMetabolism Cubicin, Tyzeka / SebivoNeuroscience Clozaril, Comtan, Extavia, FanaptOncology Exjade, Femara, Tasigna, GleevecOphthalmology LucentisRespiratory Foradil, Xolair, TOBI, Arcapta NeohalerTransplantation Myfortic, Simulect, Neoral, ZortressVirology/ Anti – invectives Cubicin, Tyzeka / SebivoOther Lamisil, Famvir, Riamet, Voltaren, Reclast
  • 12. Alcon (Eye Care)Surgical Infiniti , Constellation,intraocular lenses ,Ophthalmic Pharmaceuticals Travatan, Moxeza, Pataday,NevanacVision Care Air Optix brand of breathablecontactlenses, Dailies, FreshLookcolored lenses
  • 13. Sandoz(Generics)Anti-coagulant Lovenox®Anti-infective Augmentin®Respiratory system Fluimucil®Hypertension Lotrelc®Analgesic Duragesic®Proton pump inhibitor Prevacid®Ulcer & heartburn treatment Prilosec®Cholesterol lowering treatment Zocor®Transplantation Prograf®
  • 14. OTCNasal decongestant OtrivinPaediatric nasal decongestant ProRhinelCough suppressant SinecodAntihistamine Tavegyl/TavistCough and cold treatment TherafluPaediatric cough and cold treatment TriaminicCough/ Cold/ Respiratory
  • 15. Contd……Fiber supplement BenefiberLaxative Ex-LaxGas reliever Gas-XAntacid MaaloxFrequent heartburn treatment Prevacid24HRDigestive Health
  • 16. Contd……Pain reliever ExcedrinAnti-inflammatory VoltarenCalcium supplement CalSourceSkin irritation treatment FenistilAntifungal treatment LamisilSmoking cessation treatment Nicotinell/Thrive/HabitrolSystemic antivaricose treatment VenorutonPain and Others
  • 17. Vaccines and DiagnosticsSeasonal flu (influenza) Agrippal, Begrivac, Optaflu, Fluad, FluvirinH1N1 Focetriameningococcal disease Menveomeningitis Menjugatestimulating the bodys immuneresponseIXIAROTickborne encephalitis Encepur NRabies prevention RabAvertDiphtheria Quinvaxempoliovirus type 1, 2 and 3 Polioral
  • 18. Animal HealthPet Health Atopica, Capstar, Deramaxx , Fortekor,Interceptor, Milbemax, Milbemax, Prac-tic,SentinelLivestock Acatak Duostar, CLiK, Denagard, Fasinex,Vira Shield , ZOLVIXBioprotection Agita 10WG, Larvadex, Neporex, Oxyfly,Ratsnip, Spy, Virusnip
  • 19. PresenceNorwayPhilippinesPolandPortugalRussiaSlovakiaSpainSwedenSwitzerlandTaiwanTurkeyUnited KingdomUSAVenezuelaFinlandFranceGermanyGreeceHong KongHungaryIndiaIndonesiaItalyJapanKoreaMexicoArgentinaAustraliaAustriaBangladeshBelgiumBrazilCanadaChileChinaColombiaDenmarkEgyptNorway
  • 20. PharmaceuticalsAlcon Sandoz Vaccines andDiagnosticsConsumerHealthUnited States 32% 10 392 39% 4 016 32% 2 786 40% 746 17% 652Europe 32% 10 238 27% 2 710 49% 4 225 35% 658 50% 1 877Asia/Africa/Australasia26% 8 434 23% 2 395 12% 1 057 15% 273 21% 777Canada andLatin America10% 3 089 11% 1 104 7% 634 10% 181 12% 429Total 32 153 10 225 8 702 1 858 3 735EstablishedMarkets77% 24 778 76% 7 805 74% 6 402 77% 1 434 65% 2 415EmergingGrowthMarkets23% 7 375 24% 2 420 26% 2 300 23% 424 35% 1 320Total 32 153 10 225 8 702 1 858 3 7352012 NET SALES BY REGION AND SEGMENT
  • 21. 2012 NET SALES BY SEGMENT% USD in millionsPharmaceuticals 57 32 153Alcon 18 10 225Sandoz 15 8 702Vaccines and Diagnostics 3 1858Consumer Health 7 3735Total 56 673
  • 22. Pharmaceuticals :- Sales : Rs. 330.5 Cr. (Half year ended September 2012) Growth : 11.8%OTC :-Sales : Rs. 48.2 cr. (Half year ended September 2012)Growth : - 10.07%Animal Health :-Sales : Rs. 47.6 Cr. (Half year ended September 2012)Growth : 16.95%Sandoz(Generics):-Sales : Rs. 30.6 Cr. (Half year ended September 2012)Growth : 5.15%Net sales (India)
  • 23. Stock Price of NovartisBSE:500672BSE 590.00 4.05 (+0.69%)VOLUME 42,989PREV. CLOSE 585.95OPEN PRICE 587.95BID PRICE (QTY.) 590.00 (1,510)OFFER PRICE (QTY.) 0.00 (0)YESTERDAYS LOW/HIGH 583.10 594.0052 WK LOW/HIGH 574.00 934.20(as per 14/3/13 data)
  • 24. ROLE OF R&D• Targeting rare and neglected diseases• Ethical research• Responsible R&D
  • 25. R&D LOCATIONS OF NOVARTIS• NIBR PHARMA DEVELOPMENT-EMERYVILLE US -INDIA-LA JOLLA CALIFORNIA US -CHINA- FORT WORTH TX USA -JAPAN-CAMBRIDGE US-EAST HANOVER US-HORSHAM UK VACCINES AND DIAGNOSTIC-BASEL SWITZERLAND -US-SIENA ITALY -ITALY-SINGAPORE-SHANGHAI CHINA
  • 26. References• Balance Sheet (2012) of Novartis• http://www.fiercebiotech.com/story/novartis-lists-its-top-blockbuster-prospects-11-15/2011-07-19• http://management.fortune.cnn.com/tag/blockbuster-drugs/• http://www.novartis.com/• http://www.novartis.com/products/pharmaceuticals-therapeutic-area.shtml• http://www.novartis.com/products/index.shtml